The MRI-based ROI was used to extract the [18F]FDG activity concentration (Bq/ml) on the PET data. PET pharmacokinetic modeling was applied using the irreversible 2TCM (PMOD v.4.3, PMOD technologies) and its suitability evaluated by Schwartz Criterion (SC), Akaike Information Criterion (AIK) and Model Selection Criterion (MSC). Furthermore, rate constants were calculated for K1, k2, k3, and macro parameters MRGlu and Flux derived. The image derived input function (idIF) was segmented from the inferior vena cava as it provides a robust estimation of the idIF (28 (link)) with special regard to the spill-in contamination from neighboring tissue when using the heart (29 (link)).
Free full text: Click here